NCT02912247 2019-03-07Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy VolunteersInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Completed183 enrolled